Check-Cap Ltd (7CC) - Total Assets
Based on the latest financial reports, Check-Cap Ltd (7CC) holds total assets worth €377.00K EUR (≈ $440.75K USD) as of December 2024. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See what is Check-Cap Ltd's book value for net asset value and shareholders' equity analysis.
Check-Cap Ltd - Total Assets Trend (2016–2024)
This chart illustrates how Check-Cap Ltd's total assets have evolved over time, based on quarterly financial data.
Check-Cap Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Check-Cap Ltd's total assets of €377.00K consist of 70.3% current assets and 29.7% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0.0% |
| Accounts Receivable | €0.00 | 0.0% |
| Inventory | €0.00 | 0.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €0.00 | 0.0% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2016–2024)
This chart illustrates how Check-Cap Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 7CC stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Check-Cap Ltd's current assets represent 70.3% of total assets in 2024, a decrease from 96.6% in 2016.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2024, down from 94.7% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2016.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Check-Cap Ltd Competitors by Total Assets
Key competitors of Check-Cap Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
|
Eurofins-Cerep SA
PA:ALECR
|
France | €84.58 Million |
|
Inoviq Ltd
AU:IIQ
|
Australia | AU$24.52 Million |
|
Bcal Diagnostics Ltd
AU:BDX
|
Australia | AU$7.17 Million |
|
Imagion Biosystems Ltd
AU:IBX
|
Australia | AU$932.48K |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$510.21 Million |
Check-Cap Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.15 | 18.69 | 3.01 |
| Quick Ratio | 0.15 | 18.69 | 3.01 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-1.55 Million | €23.53 Million | €5.63 Million |
Check-Cap Ltd - Advanced Valuation Insights
This section examines the relationship between Check-Cap Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.35 |
| Latest Market Cap to Assets Ratio | 26.29 |
| Asset Growth Rate (YoY) | -98.5% |
| Total Assets | €377.00K |
| Market Capitalization | $9.91 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Check-Cap Ltd's assets at a significant premium (26.29x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Check-Cap Ltd's assets decreased by 98.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Check-Cap Ltd (2016–2024)
The table below shows the annual total assets of Check-Cap Ltd from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €377.00K ≈ $440.75K |
-98.49% |
| 2023-12-31 | €25.02 Million ≈ $29.25 Million |
-44.95% |
| 2022-12-31 | €45.44 Million ≈ $53.13 Million |
-18.36% |
| 2021-12-31 | €55.66 Million ≈ $65.07 Million |
+183.42% |
| 2020-12-31 | €19.64 Million ≈ $22.96 Million |
+108.27% |
| 2019-12-31 | €9.43 Million ≈ $11.02 Million |
-38.92% |
| 2018-12-31 | €15.44 Million ≈ $18.05 Million |
+95.24% |
| 2017-12-31 | €7.91 Million ≈ $9.24 Million |
-35.70% |
| 2016-12-31 | €12.29 Million ≈ $14.37 Million |
-- |
About Check-Cap Ltd
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.